<DOC>
	<DOCNO>NCT01577849</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetic characteristic DP-R206 ( 150mg Ibandronate / 24,000 IU Vitamin D3 complex tablet , qd ) Vitamin D3 ( 24,000 IU Vitamin D3 , qd ) oral administration healthy adult volunteer .</brief_summary>
	<brief_title>Safety Pharmacokinetic Characteristics DP-R206 ( Vitamin D3 ) Healthy Adult Volunteers</brief_title>
	<detailed_description>The number patient thirty-six . Patients randomly assign either Vitamin D3 tablet ( 24,000 IU Vitamin D3 , qd ) first , DP-R206 ( 150mg Ibandronate / 24,000 IU Vitamin D3 complex tablet , qd ) Second DP-R206 ( 150mg Ibandronate / 24,000 IU Vitamin D3 complex tablet , qd ) first , Vitamin D3 tablet ( 24,000 IU Vitamin D3 , qd ) second .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Ibandronic acid</mesh_term>
	<criteria>20 55 year healthy volunteer Hypersensitivity Reaction Ibandronate drug ( aspirin , antibiotic )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>